Your browser doesn't support javascript.
loading
Influenza Vaccine Effectiveness Against Hospitalization in Fully and Partially Vaccinated Children in Israel: 2015-2016, 2016-2017, and 2017-2018.
Segaloff, Hannah E; Leventer-Roberts, Maya; Riesel, Dan; Malosh, Ryan E; Feldman, Becca S; Shemer-Avni, Yonat; Key, Calanit; Monto, Arnold S; Martin, Emily T; Katz, Mark A.
Afiliação
  • Segaloff HE; University of Michigan School of Public Health, Ann Arbor.
  • Leventer-Roberts M; Clalit Health Services, Clalit Research Institute, Tel Aviv.
  • Riesel D; Clalit Health Services, Clalit Research Institute, Tel Aviv.
  • Malosh RE; University of Michigan School of Public Health, Ann Arbor.
  • Feldman BS; Clalit Health Services, Clalit Research Institute, Tel Aviv.
  • Shemer-Avni Y; Soroka University Medical Center, Beer Sheva.
  • Key C; Clalit Community Division, Clalit Health Services, Tel Aviv.
  • Monto AS; University of Michigan School of Public Health, Ann Arbor.
  • Martin ET; University of Michigan School of Public Health, Ann Arbor.
  • Katz MA; University of Michigan School of Public Health, Ann Arbor.
Clin Infect Dis ; 69(12): 2153-2161, 2019 11 27.
Article em En | MEDLINE | ID: mdl-30753347
ABSTRACT

BACKGROUND:

Influenza vaccine effectiveness (VE) varies by season, circulating influenza strain, age, and geographic location. There have been few studies of influenza VE among hospitalized children, particularly in Europe and the Middle East.

METHODS:

We estimated VE against influenza hospitalization among children aged 6 months to 8 years at Clalit Health Services hospitals in Israel in the 2015-2016, 2016-2017, and 2017-2018 influenza seasons, using the test-negative design. Estimates were computed for full and partial vaccination.

RESULTS:

We included 326 influenza-positive case patients and 2821 influenza-negative controls (140 case patients and 971 controls from 2015-2016, 36 case patients and 1069 controls from 2016-2017, and 150 case patients and 781 controls from 2017-2018). Over all seasons, VE was 53.9% for full vaccination (95% confidence interval [CI], 38.6%-68.3%), and 25.6% for partial vaccination (-3% to 47%). In 2015-2016, most viruses were influenza A(H1N1) and vaccine lineage-mismatched influenza B/Victoria; the VE for fully vaccinated children was statistically significant for influenza A (80.7%; 95% CI, 40.3%-96.1%) but not B (23.0%; -38.5% to 59.4%). During 2016-2017, influenza A(H3N2) predominated, and VE was (70.8%; 95% CI, 17.4%-92.4%). In 2017-2018, influenza A(H3N2), H1N1 and lineage-mismatched influenza B/Yamagata cocirculated; VE was statistically significant for influenza B (63.0%; 95% CI, 24.2%-83.7%) but not influenza A (46.3%; -7.2% to 75.3%).

CONCLUSIONS:

Influenza vaccine was effective in preventing hospitalizations among fully vaccinated Israeli children over 3 influenza seasons, but not among partially vaccinated children. There was cross-lineage protection in a season where the vaccine contained B/Victoria and the circulating strain was B/Yamagata, but not in a season with the opposite vaccine-circulating strain distribution.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana / Hospitalização Limite: Child / Child, preschool / Female / Humans / Infant / Male País/Região como assunto: Asia Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana / Hospitalização Limite: Child / Child, preschool / Female / Humans / Infant / Male País/Região como assunto: Asia Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2019 Tipo de documento: Article